Tag Archives: NSCLC

Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression

Good news for patients with non-small-cell lung cancer (NSCLC)!  If you have NSCLC, you might like to ask your oncologist to check whether you have high expression of EGFR.  Patients with high EGFR expression represented about 25 percent of people … Continue reading

Posted in Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , | Comments Off on Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression

New Monoclonal Antibodies Increased Survival in Lung Cancer Patients

A new study showed that non-small-cell lung cancer (NSCLC) patients who have high level of Met proteins in their tumor can have their survival increase three-fold by receiving experimental antibody MetMAb in combination with erlotinib (Tarceva).  In the trial, 137 previously-treated … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , | Comments Off on New Monoclonal Antibodies Increased Survival in Lung Cancer Patients

Another New Cancer Drug Crizotinib Shows Improvement in Survival

It looks like a number of new drugs might become available to lung cancer patients in the near future.  Results of an early-stage study suggested that nearly two-thirds of patients with late stage non-small-cell lung cancer who received the experimental … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , | Comments Off on Another New Cancer Drug Crizotinib Shows Improvement in Survival

Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, but most patients (over 69%) were diagnosed at advanced stages.  Although polysaccharide peptides (PSP), isolated from the fungus Yunzhi (Coriolus versicolor), have been reported to have anti-tumor effects … Continue reading

Posted in Alternative Medicine, Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer

Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer

Currently, no treatment exists for lung cancer patients with epidermal growth-factor receptor (EGFR) mutation who have failed tyrosine kinase inhibitors, getifinib (Iressa) or erlotinib (Tarceva).  However, an investigational drug, afatinib (BIBW 2992), was recently found to increase progression-free survival and … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , , , | Comments Off on Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer

First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

Is Shark Cartilage Helpful For Cancer Patients?

Shark cartilage has been touted as a potential alternative or complementary cancer treatment for several decades. Dozens of shark cartilage products are sold as dietary supplements, but none have been studied in humans. A recently published study indicated that adding a … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer, Tea | Tagged , , , , , , | Comments Off on Is Shark Cartilage Helpful For Cancer Patients?

Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC.  However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , | Comments Off on Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

Alternative Treatment Options for Late Stage Lung Cancer Patients

Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients.  However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading

Posted in Cancer, Lung Cancer | Tagged , , , , , , , , | Comments Off on Alternative Treatment Options for Late Stage Lung Cancer Patients